SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The political economy of the pharmaceutical industry.
7 references·12 citing·40 second hop
The political economy of the pharmaceutical industry. (1986)The political economy of the pharmaceutic…The Rate of Obsolescence Of Knowledge, Research Gestation Lags, and the Private Rate of Return to Research Resources (1979)The Rate of Obsolescence Of K…"Innovation in the Pharmaceutical Industry". (1978)"Innovation in the Pharmaceut…Social and Private Rates of Return from Industrial Innovations* (1977)Social and Private Rates of R…Research and Innovation in the Modern Corporation (1973)Research and Innovation in th…An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments (1973)An Evaluation of Consumer Pro…Industrial research and technological innovation (1968)Industrial research and techn…Market Structure, Product Differentiation, and Industrial Research (1967)Market Structure, Product Dif…Innovation and the Evolution of Industries: History-Friendly Models (2016)Innovation and the Evolution …Metrics to Value R&d: An Annotated Bibliography (2011)Metrics to Value R&d: An Anno…No pills for poor people? Understanding the disembowelment of India’s patent regime (2005)No pills for poor people? Und…Product-line expansion and resource cannibalization (2004)Product-line expansion and re…Innovation and firm‐level persistent profitability: a Schumpeterian framework (2001)Innovation and firm‐level per…Integration problems and turnaround strategies in a cross-border merger A clinical examination of the Pharmacia-Upjohn merger (2000)Integration problems and turn…Chapter 25 The pharmaceutical industry (2000)Chapter 25 The pharmaceutical…Drug patent expirations and the speed of generic entry. (1997)Drug patent expirations and t…Foreign entry and survival: Effects of strategic choices on performance in international markets (1995)Foreign entry and survival: E…Asymmetric International Minimum Quality Standards and Vertical Differentiation (1995)Asymmetric International Mini…Collaborative Integration in the Canadian Pharmaceutical Industry (1993)Collaborative Integration in …Pricing, Patent Loss and the Market For Pharmaceuticals (1991)Pricing, Patent Loss and the …Economic Welfare and the Allocation of Resources for Invention (1962)Economic Welfare and the Allocation of Resources for Invention (1972)The Private and Social Value of Information and the Reward to Inventive Activity (1978)Intangible Capital and Economic Growth (2006)Measuring the Returns to R&D (2009)How Do You Measure a “Technological Revolution”? (2010)An Evolutionary Theory of Economic Change. (1983)Capitalism, Socialism and Democracy (1997)The Theory of Economic Development (2003)Overcoming Failure: Abandonments and Delays of Innovation Projects in SMEs (2012)What Factors Affect the Persistence of an Innovation Advantage? (2015)Performance Feedback Persistence: Comparative Effects of Historical Versus Peer Performance Feedback on Innovative Search (2020)Monopoly and product quality (1978)Relaxing Price Competition Through Product Differentiation (1982)The Theory of Industrial Organization (1988)Minimum quality standards with more than two firms (1998)Institutional pressures and marketing ethics initiatives: the focal role of organizational identity (2011)When Are Private Standards More Stringent than Public Standards? (2013)Monopolistic Competition with Outside Goods (1979)Limit Pricing and Entry under Incomplete Information: An Equilibrium Analysis (1982)Generic Competition in the US Pharmaceutical Industry (2006)The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing (2006)A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION* (2010)Do subsidies to commercial R&D reduce market failures? Microeconometric evaluation studies (2000)Technology policy for a world of skew-distributed outcomes (2000)Measuring the Returns to R&D (2010)Moral hazard in physician prescription behavior (2000)Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (2004)The Transitional Gains Trap (1975)The machinery of freedom: guide to a radical capitalism (1990)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)The Theory of Technological Competition (1986)SHAREHOLDER VALUE CREATION DURING R&D INNOVATION AND COMMERCIALIZATION STAGES. (1995)Innovation and Technological Change (2003)The need for some innovative concepts of innovation: An examination of research on the diffusion of innovations (1974)The process of innovation in five industries in Europe and Japan (1976)Direct and cross scheme effects in a research and development subsidy program (2017)Why do some societies invent more than others? (1992)Innovation and diffusion in small firms: Theory and evidence (1994)Energy, the Environment, and Technological Change (2009)
this work references cited by second hop

References

  • 1968Industrial research and technological innovation797 cited
  • 1977Social and Private Rates of Return from Industrial Innovations*709 cited
  • 1979The Rate of Obsolescence Of Knowledge, Research Gestation Lags, and the Private Rate of Return to Research Resources497 cited
  • 1973An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments369 cited
  • 1967Market Structure, Product Differentiation, and Industrial Research231 cited
  • 1973Research and Innovation in the Modern Corporation217 cited
  • 1978"Innovation in the Pharmaceutical Industry".194 cited

Cited by

  • 1991Pricing, Patent Loss and the Market For Pharmaceuticals157 cited
  • 1995Asymmetric International Minimum Quality Standards and Vertical Differentiation131 cited
  • 2001Innovation and firm‐level persistent profitability: a Schumpeterian framework112 cited
  • 2016Innovation and the Evolution of Industries: History-Friendly Models86 cited
  • 2000Chapter 25 The pharmaceutical industry76 cited
  • 1997Drug patent expirations and the speed of generic entry.73 cited
  • 2004Product-line expansion and resource cannibalization46 cited
  • 1995Foreign entry and survival: Effects of strategic choices on performance in international markets

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

44 cited
  • 2000Integration problems and turnaround strategies in a cross-border merger A clinical examination of the Pharmacia-Upjohn merger26 cited
  • 2011Metrics to Value R&d: An Annotated Bibliography15 cited
  • 2005No pills for poor people? Understanding the disembowelment of India’s patent regime13 cited
  • 1993Collaborative Integration in the Canadian Pharmaceutical Industry12 cited